This week’s RGH Pharmacy
E-Bulletin reviews treatment
options for relapsed/refractory
multiple myeloma.
Access to relevant drug therapies
in Australia is summarised along
with variations in pharmacokinetics,
combinations and toxicities.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Nov 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.